Resalis Therapeutics announced today a strategic equity investment from Sanofi. The company intends to use the proceeds to accelerate the development of its lead investigational candidate, RES-010, ...

Vertex may have pivoted away from the space, but candidates in development by Arrowhead/Takeda, Wave, Korro and others could ...

He added that registries from specific companies can be useful resources, referencing Sanofi’s Rare Disease Registries which ...

Between October 21, 2024, and October 25, 2024, Essity Aktiebolag (publ) repurchased a total of 270,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved ...

AM(IST)on Monday in an upbeat market. Laurus Labs Ltd.(up 3.83 per cent), Biocon Ltd.(up 2.54 per cent), Natco Pharma Ltd.(up 1.98 per cent), Granules India Ltd.(up 1.86 per cent) and Glenmark ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...

The global injection pen market is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 7.0% from 2022 to 2033. The market is expected to escalate ...

On top of this, a stock split generally shows a company is confident about the future, with the idea that the stock could ...

Policymakers, top government officials, corporate bosses and finance executives from around the world are descending on the ...

Torrent Pharmaceuticals Ltd.(down 2.1 per cent), Aurobindo Pharma Ltd.(down 1.15 per cent), Abbott India Ltd.(down 0.92 per ...

Japanese drugmaker Chugai Pharmaceutical has announced its financial results for the third quarter of fiscal year 2024. Core revenue, core operating profit, and core net income at 868.5 billion yen ...

According to Thomas Hartung, who directs the Center for Alternatives to Animal Testing at Johns Hopkins Bloomberg School of ...